Regal Investment Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,060
Closed -$549K 478
2024
Q3
$549K Sell
8,060
-286
-3% -$16.1K 0.04% 336
2024
Q2
$353K Sell
8,346
-65
-0.8% -$3.58K 0.02% 424
2024
Q1
$581K Buy
8,411
+101
+1% +$6.39K 0.04% 330
2023
Q4
$615K Buy
8,310
+992
+14% +$65K 0.05% 289
2023
Q3
$499K Buy
7,318
+14
+0.2% +$1.19K 0.04% 294
2023
Q2
$686K Buy
7,304
+1,772
+32% +$138K 0.06% 246
2023
Q1
$375K Buy
+5,532
New +$356K 0.03% 345
2021
Q1
Sell
-2,248
Closed -$298K 144
2020
Q4
$298K Buy
+2,248
New +$272K 0.03% 362
2015
Q4
Sell
-325
Closed -$5K 462
2015
Q3
$5K Sell
325
-500
-61% -$11.5K ﹤0.01% 798
2015
Q2
$24K Buy
825
+500
+154% +$12.6K 0.01% 531
2015
Q1
$7K Hold
325
﹤0.01% 753
2014
Q4
$9K Buy
+325
New +$7.91K ﹤0.01% 646

Other funds holding EXAS

Regal Investment Advisors's EXAS Position: Q4 2024 in Review

Regal Investment Advisors sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 8,060 shares — an estimated $549K sold.

Regal Investment Advisors first reported a position in EXAS in Q4 2014 and held it in 12 quarters. The position peaked at $686K in Q2 2023. 594 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • Regal Investment Advisors reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • Regal Investment Advisors sold 8,060 Exact Sciences shares in Q4 2024, an estimated $549K.
  • Regal Investment Advisors first reported a position in Exact Sciences in Q4 2014 and held it in 12 quarters.
  • Regal Investment Advisors's Exact Sciences position peaked at $686K in Q2 2023.
  • 594 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Regal Investment Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.